PsychRounds: The Psychiatry Podcast

Apologies for our little hiatus - a couple of us had cross-country moves in June. But we're back! Today we have an episode on the rising use of recreational Kratom and pertinent tidbits to know from a psychiatry standpoint. References: https://pmc.ncbi.nlm.nih.gov/articles/PMC8924421/ https://www.ncbi.nlm.nih.gov/books/NBK585120/ https://pmc.ncbi.nlm.nih.gov/articles/PMC10846393/ https://pmc.n...

Welcome back! Today, we are looking at Modafinil and it's nuanced use in psychiatry. References: Provigil (modafinil) [prescribing information]. North Wales, PA: Teva Pharmaceuticals USA, Inc. U.S. Food and Drug Administration. Available at:  https://www.accessdata.fda.gov/drugsatfda docs/label/2015/020717s037s038lbl.pdf Schwartz JR. Modafinil in the treatment of excessive sleepiness. Drug Des...

Welcome Back! Today we are discussing the medication Naltrexone and its uses in psychiatry. References: https://www.ncbi.nlm.nih.gov/books/NBK534811/ https://pubmed.ncbi.nlm.nih.gov/24825644/ https://pubmed.ncbi.nlm.nih.gov/26798982/ https://www.nejm.org/doi/full/10.1056/NEJMct0801733 https://pubmed.ncbi.nlm.nih.gov/26798982/

Welcome back! Today, we will be discussing the placebo effect. References: https://pubmed.ncbi.nlm.nih.gov/16503356/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6003660/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556377/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3714297/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6694178 / https://www.psychiatrypodcast.com/psychiatry-psychotherapy-podcast...

Welcome back! Today we are talking all about Amantadine, and it's uses in psychiatry.

Welcome back! Today we are featuring the two FDA-approved medications for tardive dyskinesia, the VMAT2 inhibitors Valbenazine (Ingrezza) and Deutetrabenazine (Austedo). References: https://pubmed.ncbi.nlm.nih.gov/41626799/ https://www.ncbi.nlm.nih.gov/books/NBK548187/ https://pubmed.ncbi.nlm.nih.gov/41626799/

We are back with another special guest episode! Please welcome Dr. Allen Frances, who was intricately involved in the formation of both the DSM III and DSM IV, the latter of which he served as chair. https://x.com/AllenFrancesMD https://www.amazon.com/stores/author/B001HO76FU https://www.psychiatrictimes.com/authors/allen-frances-md

Welcome back! Today we will be doing a brief episode on Topiramate [Topamax], and its clinical uses in psychiatry. References : https://pubmed.ncbi.nlm.nih.gov/21438989/ https://pubmed.ncbi.nlm.nih.gov/18774432/ https://pubmed.ncbi.nlm.nih.gov/25899459/ https://pmc.ncbi.nlm.nih.gov/articles/PMC1088011/ https://pmc.ncbi.nlm.nih.gov/articles/PMC2671954/ https://pubmed.ncbi.nlm.nih.gov/38706338/ http...

Welcome back, today we are discussing a deceptively difficult topic: What makes something a psychiatric illness? We are joined by our guest Dr. Mark Ruffalo. He is a psychotherapist in private practice in Tampa, FL, and who also serves as Assistant Professor of Psychiatry at the University of Central Florida College of Medicine as well an Adjunct Assistant Professor of Psychiatry at Tufts Universi...

Welcome back! Today we are at the highly prescribed and popular benzodiazepine Lorazepam, also known as Ativan. We look at its uses in psychiatry, especially catatonia. But despite anecdotal efficacy, does the evidence hold up? References: https://www.ncbi.nlm.nih.gov/books/NBK532890/ https://pubmed.ncbi.nlm.nih.gov/36805317/ https://pubmed.ncbi.nlm.nih.gov/6120058/ https://pubmed.ncbi.nlm.nih.gov...

Welcome back! Today we are embarking into the first of hopefully several episodes on the importance of vitamins and minerals in mental health. We will specifically be looking at the role of iron deficiency in psychiatry and do an overview on some of the recent research that's been published. References: https://www.ncbi.nlm.nih.gov/books/NBK557376/ https://www.sciencedirect.com/science/article...

Welcome back! Today our topic is Nutritional Psychiatry and we've invited a special guest - Dr. Laura Lachance, who has done extensive research in the field. Along with Dr. Drew Ramsey, she has published a paper looking at an Antidepressant Food Score or AFS and more recently, she was a part of the EASe-GAD trial, a study looking at the impact of omega-3 fatty acids on anxiety. Antidepressant...

Welcome back! Today, we are hosting the highly accomplished Dr. Robert Sapolsky, PHD, a professor of professor of biology, neurology, and neurosurgery at Stanford University. He has had extensive research particularly in the field of neuroendocrinology and chronic stress, which has acted as one of the foundations of modern psychoneuroendocrinology. He is also a research associate at the Institute...

One hundred episodes later, let’s take it back to one of our very first, the Selective Serotonin Reuptake Inhibitors - with a much-needed update. Thank you to our guests, fans, and listeners. References: https://pmc.ncbi.nlm.nih.gov/articles/PMC4428540/ https://pubmed.ncbi.nlm.nih.gov/10333979⁠ ⁠https://pmc.ncbi.nlm.nih.gov/articles/PMC3663330/⁠

Welcome back! Today we have a very special episode on Alprazolam, brand-name Xanax. This benzodiazepine is one of the most commonly-prescribed and sought out psychotropic medications. https://www.ncbi.nlm.nih.gov/books/NBK538165/ https://pmc.ncbi.nlm.nih.gov/articles/PMC6769182/ https://pmc.ncbi.nlm.nih.gov/articles/PMC5846112/ https://pubmed.ncbi.nlm.nih.gov/6141930/ https://pubmed.ncbi.nlm.nih.g...

Join us today for an episode on the impact of climate change on mental health. We'll be exploring concepts like eco-anxiety, advocacy, the impact of nuclear war and practical tips. We're joined by guest Dr. Ferdnand Osuagwu, who was the former Chair of the Caucus on Climate Change and Mental Health of the American Psychiatric Association (APA) and founder of the Ferdnand Foundation International,...

Today, we are talking about a very popular, yet controversial class of medications - the Benzodiazepines . Let's look at their mechanism of action, clinical indications, pharmacology, risks, withdrawal syndromes, and prescribing guidance. And of course, we'll be tackling the question: what are the risks and benefits of long-term use? References: https://pubmed.ncbi.nlm.nih.gov/30098211/ ht...

Welcome to an introductory episode on anxiety disorders as requested by a long-time listener. References: https://pmc.ncbi.nlm.nih.gov/articles/PMC5832062/ https://pmc.ncbi.nlm.nih.gov/articles/PMC5573565/ https://deepblue.lib.umich.edu/bitstream/handle/2027.42/175862/Nesse%20Anxiety%20Disorders%20in%20Evolutionary%20Perspective%202022.pdf?sequence=1

Join us as we talk about Loxapine, an older medication that’s stood the test of time and found a niche in psychiatric practice. This is a revision of an earlier episode, after Dr. Bradley Miller chatted with Dr. Jonathan Meyer at the 2025 APA Conference. Dr. Meyer joins us at the beginning to provide an addendum to the original episode.

Welcome back! Today, we will be talking about Pregabalin, brand-name Lyrica, a similar medication to Gabapentin, and we will specifically be focusing on its use in psychiatry. What are its benefits and drawbacks compared to Gabapentin? Sources: - https://pubmed.ncbi.nlm.nih.gov/33563173/ - https://pubmed.ncbi.nlm.nih.gov/39989902/ - https://pmc.ncbi.nlm.nih.gov/articles/PMC3699256/ - https://pubme...

Welcome back! Today, we will be talking about Gabapentin, brand-name Neurontin, one of the most commonly-prescribed medications in the United States, and we will specifically be focusing on its use in psychiatry. It is commonly prescribed for anxiety disorders, alcohol use disorder, and sometimes even bipolar disorder! But what does the evidence say? Sources: https://pmc.ncbi.nlm.nih.gov/articles/...

Welcome back! Today, we have renowned guest Dr. Bruce Perry, one of the world's most influential child psychiatrists, to talk to us about his approach to trauma. We will go over Dr. Perry's Neurosequential Model of Therapeutics, which integrates neuroscience with child development. Dr. Perry is also a respected author, co-writing books like The Boy Who Was Raised As a Dog , Born for Love: Why Empa...

Welcome Back! Today we are interviewing Dr. Chris Aiken, Editor-in-Chief of the Carlat Psychiatry Report. We will be speaking about the broad spectrum of mood disorders, how Bipolar Disorder is different from Manic-Depressive Illness, affective temperaments, non-pharmacological treatments, and more! Dr. Aiken's new book, Difficult to Treat Depression , will be released later this year (2025)....

Welcome back! Today, we will review Pramipexole (Mirapex) and take a look at a recent study published in The Lancet Psychiatry  regarding its use in treatment-resistant depression. References: https://pubmed.ncbi.nlm.nih.gov/17854248/ https://pmc.ncbi.nlm.nih.gov/articles/PMC10034846/ https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(25)00194-4/fulltext

Welcome Back! We have recently partnered with Psych Congress to bring our audience access to some of their leading speakers and educators, and today's episode is with Dr. Charles Raison, a psychiatrist. This is the second part of our discussion, and we’re going to be looking at novel treatments like psychedelics and their impact on consciousness as well as whole-body hyperthermia and practices fro...